Arrowhead Pharmaceuticals (ARWR) said late Tuesday it has appointed Daniel Apel as its chief financial officer, effective May 13, succeeding Ken Myszkowski, who will retire.
Myszkowski will continue to offer his services as an employee adviser to ensure a smooth transition, the company said.
Apel previously worked as global head of financial planning and analysis at Walgreens Boots Alliance (WBA), Arrowhead said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments